Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
基本信息
- 批准号:8500481
- 负责人:
- 金额:$ 33.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至 2015-02-28
- 项目状态:已结题
- 来源:
- 关键词:CaringClinicalClinical DataCorticotropinDataDevelopmentDiseaseEndocrineEndocrinologyEvaluationFunctional disorderFutureGrowthGuidelinesInvestigationKnowledgeLeadLesionLinkMolecularMonitorNeurocognitiveNeurologic DysfunctionsOperative Surgical ProceduresOutcomeOutcome StudyPathologyPatient CarePatientsPituitary GlandPituitary Gland AdenomaPituitary NeoplasmsPlasmaPrevalenceProspective StudiesQualifyingQuality of lifeRecurrenceRecurrent tumorReportingResearch PersonnelResidual stateResourcesRiskRisk FactorsSafetySeriesSpecimenTherapy EvaluationTimeTumor BankTumor Markersbaseclinical careclinical practiceclinically significantcognitive neurosciencecohortfollow-upimprovedmolecular markerneurosurgerynovelprospectivetumortumor growth
项目摘要
PROJECT SUMMARY
This project will conduct the first comprehensive prospective study of clinically non-
functioning pituitary adenomas (CNFA). Current clinical practices for the evaluation, treatment
and follow up of patients with these pituitary adenomas are based on retrospectively collected
data, which have many shortcomings. As a result, significant gaps exist in our knowledge about
how to optimize these practices. A major barrier to improving our approach to these patients has
been the lack of prospectively collected evidence to support or change it. We will overcome this
barrier and answer the important outstanding questions about CNFA care. Aim 1 of this project
is to prospectively study asymptomatic pituitary lesions that do not require surgical intervention
in order to determine the appropriate initial evaluation and follow up as well as the safety of their
conservative, non-surgical management. Aim 2 of this project is to prospectively assess the
outcome of symptomatic CNFAs treated with surgery, the initial treatment of choice.
Recurrences after surgery are common, but cannot be reliably predicted so we will study
potential risk factors for tumor re-growth in particular the "silent" corticotroph tumor type. We will
also assess the safety of conservative follow up for patients with small tumor remnants after
surgery and determine in which of these patients RT is needed by examining the risks vs.
benefits of post-operatively RT for residual/recurrent tumors. Aim 3 of the project is to examine
for the first time, prospectively, the impact of the disease and our therapies on quality of life and
neurocognitive function in patients with CNFAs. Aim 4 of the project will be to establish a novel
bank of pituitary tumor specimens from our cohort that will be linked to the extensive clinical
data collected in our prospective study. This bank will serve as a valuable resource for future
collaborative studies of tumor markers and their clinical significance.
Our investigative team with expertise in Endocrinology, Neurosurgery, Cognitive
Neuroscience and Pathology is well qualified and equipped to undertake this study. The large
number of patients referred to the team make us well situated to conduct this study. The project
is further strengthened by its establishment of a large and unique prospectively followed cohort
of CNFA patients and by its creation of a bank of pituitary tumors that is linked to its clinical
data. This project will provide novel data on the evaluation, treatment and management of
patients with clinically non-functioning pituitary adenomas.
项目总结
该项目将进行第一个全面的前瞻性研究的临床非
功能性垂体腺瘤(CNFA)。目前的临床做法是对其进行评估、治疗
对这些垂体腺瘤患者的随访是基于回顾收集的
数据,它有很多缺点。因此,我们对以下问题的认识存在重大差距
如何优化这些实践。改进我们对这些患者的治疗方法的一个主要障碍是
缺乏前瞻性收集的证据来支持或改变这一点。我们会克服这一点的
屏障并回答CNFA护理的重要悬而未决的问题。本项目的目标1
是前瞻性地研究不需要手术干预的无症状的脑下垂体病变
为了确定适当的初步评估和后续行动以及其安全性
保守的非手术治疗。该项目的目标2是前瞻性地评估
对症状性CNFAs的治疗结果,首选手术治疗。
手术后复发很常见,但不能可靠地预测,所以我们将研究
肿瘤再生长的潜在危险因素,特别是“无症状的”促肾上腺皮质细胞肿瘤类型。我们会
同时评估术后小肿瘤残留患者保守随访的安全性。
手术并通过检查风险与
术后放疗对残留/复发肿瘤的益处。该项目的目标3是检查
第一次,前瞻性地,疾病和我们的治疗对生活质量和
CNFAs患者的神经认知功能。该项目的目标4将是建立一部小说
我们队列中的一批垂体瘤标本将与广泛的临床研究相关联
在我们的前瞻性研究中收集的数据。这家银行将成为未来的宝贵资源。
肿瘤标志物的合作研究及其临床意义。
我们的调查团队在内分泌学、神经外科、认知学方面拥有专业知识
神经科学和病理学非常有资格和装备来进行这项研究。大的
转诊给团队的患者数量使我们处于进行这项研究的有利位置。该项目
通过建立一个庞大而独特的前瞻性跟踪队列,进一步加强了
通过建立一个与其临床相关的脑垂体瘤库
数据。该项目将提供有关评估、治疗和管理的新数据。
临床上无功能的垂体腺瘤患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAMELA U FREDA其他文献
PAMELA U FREDA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAMELA U FREDA', 18)}}的其他基金
Central Mediation of Growth Hormone Effects in Humans
人类生长激素效应的中枢调节
- 批准号:
10659801 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
New Approaches to the Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
9924534 - 财政年份:2017
- 资助金额:
$ 33.31万 - 项目类别:
New Approaches to the Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
9750716 - 财政年份:2017
- 资助金额:
$ 33.31万 - 项目类别:
Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
- 批准号:
8231496 - 财政年份:2010
- 资助金额:
$ 33.31万 - 项目类别:
Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
- 批准号:
8629798 - 财政年份:2010
- 资助金额:
$ 33.31万 - 项目类别:
Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
- 批准号:
7861520 - 财政年份:2010
- 资助金额:
$ 33.31万 - 项目类别:
Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
- 批准号:
8022908 - 财政年份:2010
- 资助金额:
$ 33.31万 - 项目类别:
New Approaches to the Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
7990198 - 财政年份:2009
- 资助金额:
$ 33.31万 - 项目类别:
New Approaches to Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
7477753 - 财政年份:2005
- 资助金额:
$ 33.31万 - 项目类别:
New Approaches to Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
7279930 - 财政年份:2005
- 资助金额:
$ 33.31万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934920 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934926 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10945539 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10945543 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934927 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
Core B-Clinical Data Collection and Management Core
核心 B-临床数据收集和管理核心
- 批准号:
10555683 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
Point-of-care prognostic modeling of PTSD risk after traumatic event exposure using digital biomarkers and clinical data from electronic health records in the emergency department setting (PREDICT)
使用数字生物标志物和急诊科电子健康记录中的临床数据对创伤事件暴露后的 PTSD 风险进行护理点预后建模 (PREDICT)
- 批准号:
10884738 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
使用 CTCAE 和其他临床数据分析和解释 PRO-CTCAE,以表征药物耐受性
- 批准号:
10884103 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934921 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别:
STSS TASK ORDER - NATIONAL CLINICAL DATA COLLABORATIVE (NACDAC)
STSS 任务单 - 国家临床数据协作组织 (NACDAC)
- 批准号:
10949868 - 财政年份:2023
- 资助金额:
$ 33.31万 - 项目类别: